APOLLO‐2: A Randomized, Placebo and Active‐Controlled Phase <scp>III</scp> Study Investigating Oliceridine ( <scp>TRV</scp> 130), a G Protein–Biased Ligand at the μ‐Opioid Receptor, for Management of Moderate to Severe Acute Pain Following Abdominoplasty

Neil Singla(Huntington Hospital), Eugene R. Viscusi(Thomas Jefferson University), Mark A. Demitrack(Eli Lilly (United States)), David G. Soergel(Novartis (Switzerland)), David Burt(Social Science Research Solutions (United States)), Franck Skobieranda(Ionis Pharmaceuticals (United States)), Monica Salamea(Social Science Research Solutions (United States))
Pain Practice
June 4, 2019
Cited by 183


Related Papers